News Focus
News Focus

NSX

Followers 164
Posts 8408
Boards Moderated 0
Alias Born 01/31/2018

NSX

Re: uvaphd post# 40435

Wednesday, 07/04/2018 7:48:43 PM

Wednesday, July 04, 2018 7:48:43 PM

Post# of 111102
NO!

CELZ adheres to a strict model of using only the highest potency Stem Cells which are Adult Derived Bone Marrow Mesenchymal Stem Cells and taking absolute measures to NOT adulterate any of it so as to adhere to "not a drug" definition set by FDA.

Then, the administer this Adult Derived Bone Marrow Mesenchymal Stem Cells to the same patient During the same procedure so that they are protected by CFR 721 which I posted earlier:

Part 1271--Human cells, Tissues, and Cellular and tissue-based products
Sec. 1271015 are there any exceptions from the requirements of this part?

(b) "you are not required to comply with the requirements of this part if you are an establishment that removes HCT/P's from an individual and implants such HCT/P's into the same individual during the same surgical procedure."

My research and my opinion. My opinions is not a recommendation to buy or sell a security. Your decision whether or not to make a purchase should be based on your own due diligence.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News